Quantcast
Channel: Latest Crohn's Disease News on BioPortfolio
Viewing all articles
Browse latest Browse all 2985

TxCell SA TXCL Financial and Strategic SWOT Analysis Review Report Updated 09032018 Prices from USD $300

$
0
0
SummaryTxcell SA Txcell is a biotechnology company that develops and innovates cellbased immunotherapy utilizing antigen specific regulatory Tcells. The company's pipeline products include cartreg transplantation cartreg lupus cartreg dermatology ovasave a...

Viewing all articles
Browse latest Browse all 2985

Trending Articles